Nanotechnology for Targeted Therapy of Atherosclerosis

Seyedmehdi Hossaini Nasr; Seyedmehdi Hossaini Nasr; Xuefei Huang; Xuefei Huang; Xuefei Huang

doi:10.3389/fphar.2021.755569

Frontiers in Pharmacology (Nov 2021)

Nanotechnology for Targeted Therapy of Atherosclerosis

Seyedmehdi Hossaini Nasr,
Seyedmehdi Hossaini Nasr,
Xuefei Huang,
Xuefei Huang,
Xuefei Huang

Affiliations

Seyedmehdi Hossaini Nasr: Department of Chemistry, Michigan State University, East Lansing, MI, United States
Seyedmehdi Hossaini Nasr: Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, United States
Xuefei Huang: Department of Chemistry, Michigan State University, East Lansing, MI, United States
Xuefei Huang: Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, United States
Xuefei Huang: Department of Biomedical Engineering, Michigan State University, East Lansing, MI, United States

DOI: https://doi.org/10.3389/fphar.2021.755569
Journal volume & issue: Vol. 12

Abstract

Read online

Atherosclerosis is the major cause of heart attack and stroke that are the leading causes of death in the world. Nanomedicine is a powerful tool that can be engineered to target atherosclerotic plaques for therapeutic and diagnosis purposes. In this review, advances in designing nanoparticles with therapeutic effects on atherosclerotic plaques known as atheroprotective nanomedicine have been summarized to stimulate further development and future translation.

Published in Frontiers in Pharmacology

ISSN: 1663-9812 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: http://journal.frontiersin.org/journals/pharmacology

About the journal

Abstract

Keywords